Incisionless device could revolutionise treatment for metabolic diseases
A completely incisionless device that replicates metabolic surgery without making any cuts could surpass current technologies for managing conditions such as severe obesity and type 2 diabetes, a team led by an Indian researcher has found.
The ForePass device could provide unmatched treatment for millions of people who reject invasive surgery or do not respond to drugs, the researchers said.
The study led by Manoel Galvao Neto, from Sri Aurobindo Medical College in Madhya Pradesh, found that the ForePass endoscopic showed extraordinary efficacy in treating conditions such as severe obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis (MASH).
Results, published in the journal Gut, revealed a 79 per cent reduction in weight gain compared to the control group, suggesting it may be substantially more effective than common metabolic surgeries like gastric bypass.
The study also showed substantial improvements in how the body handles insulin and reduces glucose

By Debra Moran

From a young age, I have always been drawn to the power of words and their ability to tell a story, convey emotions, and inspire change. Growing up in the USA, I was exposed to various cultures and experiences that shaped my perspective on life and ignited my passion for writing. As an avid reader and lover of language, I pursued a career as a content writer. I have honed my skills in crafting captivating stories with Tribune Insights, a leading media company in California. My job allows me to combine my love for writing with my interest in current events and news. I believe that hard work is the key to success, and I pour my heart into every piece of content I create. Whether it's an article on breaking news or a heartfelt personal essay, I strive to make a connection with readers through my words.

Related Post